AEONNN How It Works Pillars Membership FAQ Journal AEONNNian Access Request Early Access

Creatine Forms Compared: Why Monohydrate Wins

The cheapest form has the most evidence, and every alternative is marketed on solving problems monohydrate does not actually have.

7 min read

The Short Answer

Creatine monohydrate is the most studied sports and health supplement in existence, with hundreds of trials, and it is also the cheapest form. Every alternative form is marketed on solving a problem: bloating, water retention, poor solubility, low absorption or a loading requirement. Most of those problems are either minor, avoidable or not real, and no alternative form has demonstrated superiority in a head-to-head comparison. This is the clearest case in supplementation where the cheap option is the right one.

What Monohydrate Has Behind It

Trial volume. Hundreds of randomised trials across strength, power, lean mass, exercise performance and, more recently, cognitive measures under sleep deprivation and metabolic stress.

Established mechanism. Creatine is stored in muscle as phosphocreatine, which rapidly regenerates ATP during high-intensity effort. Supplementation raises muscle creatine content, which is directly measurable.

Long-term safety data. Multi-year trials in healthy adults and clinical populations. The kidney concern that circulates is not supported in people with normal renal function, and creatine raises serum creatinine modestly through normal metabolism rather than through impairment, which matters when interpreting an eGFR.

Dose established. 3 to 5 g daily maintains saturation. A loading phase of around 20 g daily for five to seven days reaches saturation faster and is optional rather than necessary.

Breadth. Effects beyond muscle: cognitive measures under stress, larger effects in vegetarians with lower baseline stores, and interest in bone and mood with earlier evidence.

Nothing in the alternative forms approaches this evidence base, and that asymmetry is the whole comparison.

The Alternative Forms and Their Claims

FormClaimAssessment
Creatine HClBetter solubility, so lower dose neededSolubility is not the limiting factor; no head-to-head superiority demonstrated
Buffered creatineLess conversion to creatinine in stomach acidStomach conversion is minimal for monohydrate; a trial found no advantage
Creatine ethyl esterBetter absorptionDegrades more readily to creatinine; a trial found it inferior at raising muscle creatine
Creatine magnesium chelateImproved uptakeLimited data; no demonstrated advantage
Liquid creatineConvenienceCreatine degrades in solution over time; a poor format
Creatine nitrateAdded nitric oxide effectsTwo separate claims bundled; no superiority for creatine delivery
Micronised monohydrateFiner particles, better mixingGenuine minor convenience benefit; same compound

The pattern is consistent: each form addresses a proposed limitation of monohydrate that is either not the limiting factor or not a real problem, and none has shown superiority where compared directly.

Micronised monohydrate is the honest exception, since finer particles genuinely mix more easily. It is the same compound at a modest premium, which is a reasonable purchase for a convenience reason rather than an efficacy one.

The Problems Alternatives Claim to Solve

Bloating and gastrointestinal upset. Real for some people, and almost always associated with a loading phase or a large single dose. Skipping loading and taking 3 to 5 g daily with food resolves it in most cases. That is free.

Water retention. Creatine draws water into muscle cells, which is part of how it works, and it causes a small increase in body weight of roughly one to two kilograms early on. This is intracellular rather than subcutaneous and is not the same as looking puffy. It is not a reason to choose a different form, since any form raising muscle creatine does the same thing.

Poor solubility. Monohydrate dissolves adequately in warm water and settles in cold. Micronised versions mix better. Neither affects absorption, since it dissolves in the gut regardless.

Loading requirement. Optional. Daily 3 to 5 g reaches saturation in three to four weeks without any loading phase, and skipping loading avoids the main source of side effects.

Non-responders. Genuine, and roughly explained by baseline muscle creatine content: people with already high stores, particularly those eating substantial red meat and fish, gain less. A different form does not address this.

Every one of these is either solved by taking monohydrate differently or not solved by any form.

Practical Use

Dose: 3 to 5 g daily of monohydrate. Higher doses in larger individuals are reasonable, and there is no benefit to going substantially above this for maintenance.

Loading: optional. Around 20 g daily split into four doses for five to seven days reaches saturation faster, at the cost of more gastrointestinal complaints.

Timing: largely irrelevant, since the effect depends on saturation rather than acute dosing. Taking it consistently matters; taking it at a particular time does not.

With food reduces gastrointestinal effects, and taking it with carbohydrate may slightly improve uptake through insulin, which is a minor consideration.

Cycling is unnecessary. There is no evidence for a need to cycle, and stopping simply allows stores to decline over weeks.

Hydration: adequate fluid intake is sensible, and the dramatic warnings about dehydration and cramping are not supported by trial data, which if anything suggests the opposite.

Verification: not directly available to a consumer, and strength and lean mass changes over eight to twelve weeks are the practical readout, with the caveat that training is doing most of the work.

Quality and Safety Notes

Quality is a genuine consideration despite the compound being simple. Creatine production can leave contaminants including dicyandiamide, dihydrotriazine and creatinine, and third-party tested or reputably sourced product addresses this. Certification also matters for anyone in tested sport.

Serum creatinine. Creatine supplementation raises it modestly through normal metabolism, which can cause an eGFR result to be misread as reduced kidney function. Declare it before a blood test rather than stopping it.

Kidney disease. In people with normal renal function the evidence does not support harm. In existing kidney disease it warrants clinical discussion rather than assumption.

Adolescents. Widely used and less studied in that group, which is a reason for clinical input rather than a demonstrated risk.

Interactions are minimal, which makes this one of the cleaner compounds in a stack.

The verdict: buy plain monohydrate, or micronised monohydrate if you dislike the mixing, from a third-party tested source. That decision takes a minute and is correct, and every premium alternative in this category is solving a problem you can solve for free.

The AEONNN Perspective

Creatine is the clearest case in AEONNN's Evidence layer where the cheapest form is also the best supported. Monohydrate has hundreds of randomised trials, an established mechanism, measurable muscle content changes and multi-year safety data, and no alternative form has demonstrated superiority in a head-to-head comparison.

The alternatives are marketed on problems that mostly are not real. Bloating is associated with loading rather than the compound, and skipping loading resolves it for free. Water retention is intracellular and is part of the mechanism, so any effective form causes it. Solubility does not affect absorption. Loading is optional, since daily 3 to 5 g saturates in three to four weeks.

Two practical notes the platform surfaces. Creatine raises serum creatinine modestly through normal metabolism, so declaring it before a blood draw prevents an eGFR result being misread as reduced kidney function. And quality still matters despite the compound being simple, since production can leave contaminants, which makes third-party testing worth having. Micronised monohydrate is the one honest premium here, bought for mixing convenience rather than efficacy.

Database Matrix layers

  • Evidence Layer (PubMed, Cochrane, ClinicalTrials.gov)
  • Pharmacokinetics Layer (HMDB, PubChem)
  • Quality / Formulation Layer (ConsumerLab, Labdoor)
  • Safety Layer (DrugBank, FAERS)

Frequently Asked

Which form of creatine is best?

Monohydrate. It has hundreds of randomised trials, an established mechanism and multi-year safety data, and no alternative form has shown superiority in a head-to-head comparison.

Is creatine HCl better than monohydrate?

No demonstrated superiority. Its claim rests on solubility, which is not the limiting factor since monohydrate dissolves in the gut regardless.

Do I need a loading phase?

No. Daily 3 to 5 g reaches saturation in three to four weeks, and skipping loading avoids the main source of gastrointestinal complaints.

Does creatine cause bloating?

For some people, and almost always with a loading phase or a large single dose. Skipping loading and taking 3 to 5 g with food resolves it in most cases.

Does creatine cause water retention?

It draws water into muscle cells, which is part of how it works, producing a small early weight increase. It is intracellular rather than subcutaneous, and any effective form does the same.

Why does creatine affect my kidney test?

It raises serum creatinine modestly through normal metabolism rather than through impairment, which can make an eGFR look reduced. Declare it before a blood test rather than stopping it.

Is creatine safe long term?

Multi-year trials in healthy adults do not support harm at normal doses in people with normal renal function. Existing kidney disease warrants clinical discussion.

Evidence and review

Any dosage ranges cited here reflect the ranges used in published human trials, not personal recommendations. Evidence in this field moves, so this article is reviewed quarterly and carries its last-updated date above. Nothing here is intended as medical advice, and supplementation should be discussed with a qualified clinician, particularly alongside prescribed medication or an existing condition.

Continue Reading

Membership

Reading about structural and Musculoskeletal Support is not the same as knowing where you stand.

AEONNN organizes an article like this one against your own profile. Origin works through Discovered Mode, building your Pillar Matrix from the context you provide. Evolution adds Synched Mode, so supported wearable, Apple Health and laboratory data inform the same reasoning.

AEONNN turns knowledge like this into a protocol that is yours.

Private Early Access opens in August. Public launch follows in September.

By requesting access, you agree to receive AEONNN launch and membership communications. You may unsubscribe at any time. Privacy Policy · Consumer Health Data Privacy Notice

Back to the Journal →